Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al

by Mondher Toumi, Samuel Aballea
Published 2020-01-01

Measuring health-related quality of life in young children: how far have we come?

by Nicola Germain, Samuel Aballéa, Mondher Toumi
Published 2019-01-01

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.

by Ayman Chit, Julie Roiz, Samuel Aballea
Published 2015-01-01

Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population

by Mondher Toumi, Mondher Toumi, Aurélie Millier, Olivier Cristeau, Katia Thokagevistk-Desroziers, Julie Dorey, Samuel Aballéa, Samuel Aballéa
Published 2020-07-01

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts...

by Lylia Chachoua, Monique Dabbous, Clément François, Clément François, Claude Dussart, Samuel Aballéa, Samuel Aballéa, Mondher Toumi, Mondher Toumi
Published 2020-10-01

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe

by Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, Mondher Toumi
Published 2021-01-01

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results

by Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa, Mondher Toumi
Published 2019-01-01

Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review

by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée
Published 2024-04-01

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach

by Ru Han, Shuyao Liang, Clément François, Samuel Aballea, Emilie Clay, Mondher Toumi
Published 2021-01-01

Determinants of orphan drugs prices in France: a regression analysis

by Daria Korchagina, Aurelie Millier, Anne-Lise Vataire, Samuel Aballea, Bruno Falissard, Mondher Toumi
Published 2017-04-01

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

by Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa
Published 2019-01-01

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

by Zalmai Hakimi, Con Kelleher, Samuel Aballéa, Khaled Maman, Jameel Nazir, Colette Mankowski, Isaac Odeyemi
Published 2018-01-01

Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study

by John Pasi, Cédric Hermans, Zalmai Hakimi, Jameel Nazir, Samuel Aballéa, Monia Ezzalfani, Francis Fatoye
Published 2022-02-01

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models

by Michał Pochopień, Ewelina Paterak, Emilie Clay, Justyna Janik, Samuel Aballea, Małgorzata Biernikiewicz, Mondher Toumi
Published 2021-01-01

Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study

by Natalia Hawken, Zalmai Hakimi, Samuel Aballéa, Jameel Nazir, Isaac A. O. Odeyemi, Mondher Toumi

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment

by Mondher Toumi, Anastasiia Motrunich, Aurélie Millier, Cécile Rémuzat, Christos Chouaid, Bruno Falissard, Samuel Aballéa
Published 2017-01-01

A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients

by Vanessa Taieb, Hidetoshi Ikeoka, Fang-Fang Ma, Katarzyna Borkowska, Samuel Aballea, Keiko Tone, Nobuo Hirotsu
Published 2020-12-01

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease

by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov
Published 2024-04-01

Comprehensive evaluation of 45 augmentation drugs for schizophrenia: a network meta-analysisResearch in context

by Damien Etchecopar-Etchart, Dong Keon Yon, Piotr Wojciechowski, Samuel Aballea, Mondher Toumi, Laurent Boyer, Guillaume Fond
Published 2024-03-01

Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

by Natalia Hawken, Saku Torvinen, Mohamed-Elmoctar Neine, Ikbel Amri, Mondher Toumi, Samuel Aballéa, Adam Plich, Nicolas Roche
Published 2017-07-01